Home Hanyu Medical, a Leading Chinese Developer of Structural Heart Devices, Files for STAR Market IPO

Hanyu Medical, a Leading Chinese Developer of Structural Heart Devices, Files for STAR Market IPO

Dec 17, 2020 21:22 CST Updated 21:22
Hanyu Medical

Structural Heart Disease Interventional Devices and Electrophysiology Product R&D, Manufacturer

Original Title: Hanyu Medical, a High-End Cardiac Device Company, Plans to List on the STAR Market

"Sci-Tech Innovation Board Daily" reported on the 17th that a reporter from "Sci-Tech Innovation Board Daily" learned that Shanghai Hanyu Medical Technology Co., Ltd. plans to list on the Sci-Tech Innovation Board.China International Capital Corporation Limitedas its tutoring institution. Hanyu Medical, established in December 2016, is among the first batch of enterprises in China engaged in the research and development, manufacturing, and sales of interventional valvular medical devices. Currently, the company’s core product is the Valve Clamp, a mitral valve intervention device used for minimally invasive interventional treatment of mitral regurgitation. (Reporter: Wu Fan)